Zhangziyue Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhangziyue Huang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Adrienne N. Poon
Department of Medicine, School of Medicine & Health Sciences, George Washington University, Washington DC, USA
1 shared publication - Daniel Diamond Reidpath
Institute for Global Health and Development (IGHD), Queen Margaret University, Edinburgh, EH21 6UU, UK
1 shared publication - Kit Yee Chan
Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, UK
1 shared publication - Noori Srivastava
Department of Medicine, School of Medicine & Health Sciences, George Washington University, Washington DC, USA
1 shared publication - Xiaoqian Xia
Department of Public Health, Environments & Society, London School of Hygiene and Tropical Medicine, London, United Kingdom
1 shared publication - Zhicheng Wang
China Development Research Foundation, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 13 October 2023
- Published by International Society of Global Health in Journal of Global Health
- Vol. 13, 04075
A systematic review and meta-analysis of the effectiveness of hypertension interventions in faith-based organisation settings
Hypertension or high blood pressure (BP) is the global, leading cause of mortality and the main modifiable risk factor for cardiovascular disease [1–3], dementia [4], decline in kidney function [5] and severe illness and death from coronavirus disease 2019 (COVID-19) [6–8]. All these outcomes are associated with substantial health and economic costs as well as […]
- 13 October 2023
- Published by International Society of Global Health in Journal of Global Health
- Vol. 13, 04075
Open AccessA systematic review and meta-analysis of the effectiveness of hypertension interventions in faith-based organisation settings
Hypertension or high blood pressure (BP) is the global, leading cause of mortality and the main modifiable risk factor for cardiovascular disease [1–3], dementia [4], decline in kidney function [5] and severe illness and death from coronavirus disease 2019 (COVID-19) [6–8]. All these outcomes are associated with substantial health and economic costs as well as […]